UNM Virtual Human Biospecimen Repository -- Pitfalls and the Possibilities UNM Biocomputing Conference April 22, 2005 Philip J. Kroth, M.D., M.S.

Slides:

Advertisements

Similar presentations

Ann Johnson IRB Administrator, IRB Member. Objectives 1. Identify the components necessary for management and oversight of tissue repositories used for.

Advertisements

TISSUE BANKING Challenging to Say the Least

Overview of the VCU Clinical Trials Office

1 The HIPAA Privacy Rule and Research This presentation will probably involve audience discussion, which will create action items. Use PowerPoint to keep.

HIPAA – Privacy Rule and Research USCRF Research Educational Series March 19, 2003.

1 HIPAA and Research and YOU. 2 INTRODUCTION Rule #1:Don’t Panic Rule #2:Bottom Line for Researchers: HIPAA is Manageable thru Education/Awareness and.

Ethical Considerations in Human Subjects Research Stacey Berg, M.D. Texas Children’s Cancer Center.

PERMISSION ONTOLOGY FOR INFORMED CONSENT AND HIPAA COMPLIANCE Maria Adela Grando PhD Division Biomedical Informatics, University California.

Health Insurance Portability Accountability Act of 1996 HIPAA for Researchers: IRB Related Issues HSC USC IRB.

Methods repositories use to protect subjects Roger Aamodt, Ph.D. Resources Development Branch, National Cancer Institute.

CHOICE Pathology Informatics 2010 Boston, Massachusetts DataReady ® : A Deployable Data Management and Integration System for Large-scale Cancer Repositories.

1 Information Security for HIPAA Third Meeting for Researchers M. Caputo March 25, 2003.

CUMC IRB Investigator Meeting November 9, 2004 Research Use of Stored Data and Tissues.

1 Preparing for HIPAA Third Meeting for Researchers Mike Hawkins FAHC Director of Risk Management March 25, 2003.

Northern England Strategic Clinical Network Conference 15 th May 2015 Haemosys System David Bottoms Diagnostic Project Manager.

Opportunities for Big Data in Medical Records Mike Conlon, PhD

Developing A Repository Protocol Kathleen T. Uscinski. MBA, CIP April 25, 2006.

IDR Snapshot: Quantitative Assessment Methodology Evaluating Size and Comprehensiveness of an Integrated Data Repository Vojtech Huser, MD, PhD a James.

Medical Research BADRAG meeting Jan 2013 Dr H Sari-Kouzel.

Secretary’s Advisory Committee on Heritable Disorders of Newborns and Children September 22, 2011 Newborn Screening Translational Research Network (NBSTRN)

Are IRBs Efficient, Effective, or Redundant? David C. Clark, Ph.D. Director, Research Compliance Rush University Center.

Human Research Protection Programs 1a: How to Navigate Human Subject Protection Regulations Sponsored by the American Society for Investigative Pathology.

Treuman Katz Center for Pediatric Bioethics Conference Banking Biological Samples for Pediatric Research Jeffrey R. Botkin, M.D., M.P.H. Professor.

Shared Health Research Information Network Andrew McMurry, MS SHRINE Architect Harvard Medical School Center for BioMedical Informatics Children’s Hospital.

Consent2Share Linking Cohort Discovery to Consent David R Nelson MD Assistant Vice President for Research Professor of Medicine Director, Clinical and.

Biorepository Software Selection University of Michigan 31-Aug-2012 Frank Manion, Chief Information Officer Paul McGhee, Lead Business Analyst Cancer Center.

Tissue Bank Challenges Repository and Pathologist View Elizabeth H. Hammond M.D.

OnCore Roll Out April 8, 2011.

Newborn Screening Translational Research Network Coordinating Center Duane Alexander, M.D. Director, Eunice Kennedy Shriver National Institute of Child.

SACHRP HIPAA Recommendations: September 2004 Mark Barnes Huron Consulting Group March 3, 2009.

Research with the Human Tissue Repository RAFT Session April 10, 2015 Corey C Ford, MD, PhD Sr. Associate Dean for Research.

Implications for the Use of Tissue in Research P. Pearl O’Rourke, MD Partners HealthCare Boston, MA.

1 Jack London, PhD Research Professor, Cancer Biology Thomas Jefferson University Informatics Shared Resource Director Sidney Kimmel Cancer Center at Jefferson.

HIPAA – How Will the Regulations Impact Research?.

CRIMSON: Sample Management in i2b2 Dr. Lynn Bry Oct 2010.

Ethical and Regulatory Considerations in Research using Residual Specimens Jeffrey R. Botkin, M.D., M.P.H. Professor of Pediatrics and Medical Ethics Associate.

Integrated Data Management System for the Biorepository.

Joyce Mull, MPM Director, Regulatory Affairs National Surgical Adjuvant Breast and Bowel Project Consent Form and IRB Challenges that Arise with Specimen.

H I P A A T R A I N I N G Self Directed Module 7 Research Disclosures For Data Custodians START Click to begin…

Issues and Challenges for Integrated Surveillance Systems Daniel M. Sosin, MD, MPH Division of Public Health Surveillance and Informatics Epidemiology.

Data, Security and Human Subjects Research Deborah Barnard, MS.

Integrating a Federated Healthcare Data Query Platform With Electronic IRB Information Systems Shan He IPHIE 2010.

Clinical Research Informatics at the University of Michigan Daniel Clauw M.D. Professor of Medicine, Division of Rheumatology Assistant Dean for Clinical.

IT Infrastructure Planning Committee Use Case Enhanced SVS Nikolay Lipskiy, MD, DrPH, Centers for Disease Control (CDC), USA Sundak Ganesan, MD, Northrop.

Use of Data from the Electronic Medical Record in Research Opportunities & Pit Falls Kristin West.

Research Involving Human Specimens Marianna Bledsoe, M.A VA Local Accountability for Research Meeting June 2, 2011.

Clinical Research and Outcomes Registry Workshop Creating an Informed Consent Form Daniel Ford, MD, MPH Joseph Carrese, MD.

The TJU Human Research Protection Program (HRPP): Part I – Which Entities/Offices are Involved ? J. Bruce Smith, MD, CIP.

NCI Community Cancer Centers Program (NCCCP) Kate Castro, RN, MS, AOCN ® Nurse Consultant National Cancer Institute, Outcomes Research Branch Kate Castro,

PathoSys ® NEPath Project Update 6 th September 2011.

The VA Central irb opportunities and challenges

May 2007 CTMS / Imaging Interoperability Scenarios March 2009.

Informatics Tools and Services Biomedical Informatics Core Tim Aro.

Facilitating tissue collection for translational research Jane Rogan Business Manager.

OHRP Update Michael A. Carome, M.D. Associate Director for Regulatory Affairs Office for Human Research Protections 3 rd Annual Medical Research Summit.

Honest Brokers for Secure De- identification of Patient Records Project – CSE 5810 – Introduction to Biomedical Informatics Krishna Kalaparti Date: 04/20/2016.

Research and Reporting

Managing Patient Contact Studies at a Central Registry

Million Veteran Program Data Marts and Data Access

Piloting IRBchoice at Vanderbilt

of Pathology Specimens for the VA Precision Oncology Program

Bozeman Health Clinical Research

FaceBase Biorepository: Overview

The HIPAA Privacy Rule and Research

The Genetic Basis for Cancer Treatment Decisions

Big Data Danielle Leach Rudy Morgan Deborah Tobin Stacie Lindsay

Presented by: Don Green

REACHnet: Research Action for Health Network

Presentation transcript:

UNM Virtual Human Biospecimen Repository -- Pitfalls and the Possibilities UNM Biocomputing Conference April 22, 2005 Philip J. Kroth, M.D., M.S.

Overview Why build the UNM Tissue Repository? What is the UNM Tissue Repository? What are the key regulatory issues? What is the proposed pilot project structure?

Why Build the UNM Tissue Repository? Linking clinical, genetic, and demographic information with human biospecimens significantly increases their value for research Supports growing regulatory and privacy requirements Can facilitate more efficient use of a very scarce and valuable resource

What is the UNM Tissue Repository? Virtual database of (eventually) all human biospecimens at UNM HSC Structured and coded (using SNOMED) in a standardized manner to facilitate: –Queries across UNM institutional boundaries to find tissue available for research –Linking with other databases including clinical data Designed to be consistent with the National Biospecimen Network Blueprint

Regulatory Issues Human Tissue Oversight Committee Human Research Review Committee Four defined types of tissues: –Type A Excess tissue alternatively prepared for possible future diagnostic purposes. (No IRB oversight or consent status as tissue prepared for diagnostic studies only.) –Type B Excess tissue alternatively prepared for a known HRRC- approved active research project with HRRC-approved consent status. –Type C Excess tissue alternatively prepared for unknown future research project with Tissue Repository consent of patient. –Type D Excess tissue alternatively prepared for unknown future research project with waiver of informed consent, waiver of HIPAA authorization, Tissue Repository as honest broker for identifiers and dispensed as de-identified samples.

Proposed Pilot Project Structure Oracle Database Server TissueMetrix PC Workstation Pilot Year-1 Web-Based Queries Potential Future Expansion Potential Cerner Clinical System UNM Tumor Registry SEER Data Velos Cancer Trial Tracking System Tri-Core Labs Others?

For More Information

Questions?

UNM Virtual Human Biospecimen Repository -- Pitfalls and the Possibilities UNM Biocomputing Conference April 22, 2005 Philip J. Kroth, M.D., M.S.